High fasting serum glucose in non-diabetic subjects ≥45 years is an indicator of future cardiovascular events as it is positively associated with atherogenic index of plasma

References

• Dobiasova M. (2004). Atherogenic Index of Plasma Log [(Triglycerides/HDL-Cholesterol)]: Theoretical and practical implications. Clin Chem 50(7):1113–1115.
   PubMed Web of Science ®Google Scholar
• Dobiásová M. (2006) AIP – atherogenic index of plasma – as a significant predictor of cardiovascular risk: From research to practice. Vnitr Lek 52(1):64–71.
   PubMedGoogle Scholar
• Dobiasova M, Frohlich J. (2001) The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apo B-lipoprotein-depleted plasma (FERHDL). Clin Biochem 34(7):583–588.
   PubMed Web of Science ®Google Scholar
• Dobiavosa M, Urbanova Z, Samanek M. (2005) Relation between particle size of HDL and LDL lipoproteins and cholesterol esterification rate. Physiol Res 54(2):159–165.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. (1972). Estimation of the concentration of LDL cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18(6):499–502.
   PubMed Web of Science ®Google Scholar
• Geohas J, Daly A, Juturu V, Finch M, Komorowski JR. (2007). Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Am J Med Sci 333(3):145–153.
   PubMed Web of Science ®Google Scholar
• Hokanson JE, Austin MA. (1996) Plasma triglyceride level is a risk factor for cardio vascular disease independent of high density lipoprotein cholesterol level: A meta analysis of population based prospective studies. J Cardiovasc Risk 3(2):213–219.
   PubMedGoogle Scholar
• Kvan E, Pettersen KI, Sandvik L, Reikval A. (2007). High mortality in diabetic patient with acute myocardial infarction: Cardiovascul arco-morbidities contribute most to the high risk. Int J Cardiol 121(2):184–188.
   PubMed Web of Science ®Google Scholar
• Levitan EB, Song Y, Ford ES, Liu S. (2004). Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164(19):2147–2155.
   PubMed Web of Science ®Google Scholar
• McGee DL. (2005). Body mass index and mortality: A meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 15(2):87–97.
   PubMed Web of Science ®Google Scholar
• Mendis S, Puska P, Norrving B. (2011) Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization.
   Google Scholar
• Norhammar A, Malmberg K, Diderhol E, Lagerqvist B, Lindahl B, Ryden L. (2004). Diabetes mellitus: The major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 43(4):585–591.
   PubMed Web of Science ®Google Scholar
• Nwagha UI, Ikekpeazu EJ, Ejezie FE, Neboh EE, Maduka IC. (2010) Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. Afr Health Sci 10(3):248–252.
   PubMed Web of Science ®Google Scholar
• Rao SS, Disraeli P, McGregor T. (2004). Impaired glucose tolerance and impaired fasting glucose. Am Fam Physician, 69(8):1961–1968.
   PubMed Web of Science ®Google Scholar
• Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F. (2006). Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368(9536):666–678.
   PubMed Web of Science ®Google Scholar
• Sharma TK, Parchwani H, Kaushik GG, Shankar V, Dahiya K, Ghalaut VS, Sharma N. (2011). HbA(1c) levels in cardiovascular diseased patients without diabetes in a developing country. Clin Lab 57(7–8):517–522.
   PubMed Web of Science ®Google Scholar
• Tan MH, Johns D, Glazer NB. (2004) Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin Chem 50(7):1184–1188.
   PubMed Web of Science ®Google Scholar
• Tan MH, Johns D, Strand J, Halse J, Madsbad S, Eriksson JW, Clausen J, Konkoy CS, Herz M. (2004). Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes. Diabet Med 21(8):859–866.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. (2001). National Cholesterol Education Program [online]. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/atglance [Accessed 20 December 2012].
   Google Scholar
• Yang D, Liu X, Xiang M. (2011). The correlation between lipids ratio and degree of coronary artery stenosis. High Blood Press Cardiovasc Prev18(2):53–56.
   Google Scholar